David Lazar is currently the CEO of both Custodian Ventures LLC & Activist Investing which specializes in "Turnaround Situations" via Activist Investing in distressed public companies. He along with his team are actively seeking high growth private companies who are looking to explore transitioning into the public markets.

David has been involved in the Capital Markets for nearly a decade. He has diverse knowledge of financial, legal and operations management; public company management, accounting, private placements, audit preparation, capital raising, due diligence reviews, and SEC regulations.

Other expertise include: capital restructuring, reverse merger, debt financing, SPAC, equity lines, and mergers and acquisitions. David has additional experience in assisting OTC listed companies prepare for a Nasdaq Uplisting.
At Activist Investing, we look for “diamonds in the rough". Companies which have long lost favour in the eyes of Wall Street and drastically need a comeback. We seek to invest in companies for which we can actively work with management in order to restore much needed shareholder value.

In other investment scenarios, when management is already on the right track, we merely invest to join in for the ride. Although this investment strategy comes with substantial high risk, we believe that it can bear great reward. Through our meticulous Due Diligence process that is conducted on every potential investment, we feel that we can properly mitigate our risk.


As Warren Buffett once said, “fearful when others are greedy, and greedy when others are fearful.”

We invest in distressed assets from large parent companies on the private side in need of restructuring. Before any investment is made, our team assesses the division's operations, including its management team, employees, processes, and systems. Identify areas of inefficiency or weakness that may require restructuring or investment. 

After acquiring the company, our main objective is to take an active role in the company's operations or working with management to implement changes that can improve the company's performance.

The Reverse Merger Alternative to an IPO: Technique Gaining Traction in Life Sciences Sector

Source: wilmerhale.com In recent years a variety of alternative paths to public ownership and trading liquidity have emerged. The reverse merger is both one of the newest and among the oldest alternative to a conventional IPO for a private company seeking to become publicly traded.

Read More  
5 min read

Startups Opt For Microcap Mergers To Tap Public Markets

Source: news.crunchbase.com Most years, at least a few buzzy startups manage to carry out high-profile IPOs. But lately, with the window for large new offerings frozen shut, those debuts aren’t happening.

Read More  
3 min read

Titan Pharmaceuticals Announces Board Expansion and Management Changes

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board") from five (5) to eleven (11) and appointed six new directors following their election at its special meeting of stockholders held on August 15, 2022 (the "Special Meeting").

Read More  
4 min read

Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of Stockholders

NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) with 25.2% of the Company’s outstanding shares, today issued the following statement:

Read More  
4 min read

Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest stockholders of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“TTNP” or the “Company”) with 9.9% of the Company’s outstanding shares, today issued the following statement:

Read More  
1 min read

Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

Read More  
1 min read

Electro-Sensors and Mobile X Global Announce Merger

MINNETONKA, Minn. and LOS ANGELES, June 13, 2022 /PRNewswire/ -- Electro-Sensors, Inc. (Nasdaq: ELSE), a leader in industrial monitoring systems, and Mobile X Global, Inc., one of the world's first connectivity-as-a-service companies, announced today that they have entered into definitive agreements to merge and re-name the combined company Mobile X Global, Inc.

Read More  
7 min read

Activist Investing LLC Announces 5.7% Ownership Interest in Electro-Sensors, Inc.

NEW YORK, NY Jan. 14, 2022 (GLOBE NEWSWIRE) Activist Investing LLC Announces 5.7% Ownership Interest in Electro-Sensors, Inc.

Read More  
1 min read

David E. Lazar Announces 5.1% Ownership Interest in Insignia Systems, Inc.

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, an experienced private investor specializing in reverse merger and other event-driven opportunities, today filed a Schedule 13D announcing his acquisition of approximately 5.1% of the common stock outstanding of Insignia Systems, Inc. (NASDAQ: ISIG) (“ISIG” or the “Company”).

Read More  
1 min read

Untethered SPACs are Rushing to Merge Before Their Founders Lose Money

Source: fool.com, Do deadlines stress you out? Trigger warning: don't read the following story. Just about 300 SPACs have to find a company to merge with in the next three quarters or their investors risk losing money they put in, according to figures from data provider SPAC Research seen by The Wall Street Journal.

Read More  
1 min read

Truly Terrible SPAC Performers Explore Lower Lows In 2022

Source: news.crunchbase.com - Reviewing aftermarket performance of venture-backed companies that went public via SPAC lately feels a lot like watching one of those documentaries exploring the Mariana Trench.

Read More  
2 min read

Custodian Ventures Announces 5.2% Ownership Interest in LM Funding America, Inc.

NEW YORK, NY July 29, 2021 (GLOBE NEWSWIRE) -- Custodian Ventures LLC (together with its affiliates, “Custodian Ventures” or “we”), today filed a Schedule 13D announcing its acquisition of approximately 5.2% of the common stock outstanding of LM Funding America, Inc. (NASDAQ: LMFA) (“LMFA” or the “Company”).

Read More  
1 min read
SPAC VS "Ordinary" Reverse Merger
1 min read
  •  20/12/2020 03:04 PM

Long before SPACs became a big hit on Wall St. there were “ordinary” Reverse Mergers on the Nasdaq & NYSE with small operating companies that no longer had a need to be public.

Read More  
Current Environment Of Filing S-1’s, 15c2-11’s, And DTC Eligibility
4 min read
  •  22/06/2020 10:49 AM

So before we begin let’s start by defining a few key terms: 1. S-1 is a registration statement filing that gets submitted for examination and final approval by the SEC. Once approved the company can raise money based upon the terms set forth within the S-1 (i.e.) minimum/maximum of…

Read More  

Contact Form

*
*